Breaking News Instant updates and real-time market news.

KMB

Kimberly-Clark

$136.44

-2.09 (-1.51%)

, JNJ

Johnson & Johnson

$141.27

0.295 (0.21%)

15:01
07/09/19
07/09
15:01
07/09/19
15:01

Kimberly-Clark appoints Alison Lewis to newly created Chief Growth Officer role

Kimberly-Clark (KMB) announced the appointment of Alison Lewis to the newly created position of Chief Growth Officer. Lewis joins Kimberly-Clark from Johnson & Johnson (JNJ), where she served as Chief Marketing Officer of the Global Consumer business since 2013. She will join Kimberly-Clark at the end of July, the company reported.

KMB

Kimberly-Clark

$136.44

-2.09 (-1.51%)

JNJ

Johnson & Johnson

$141.27

0.295 (0.21%)

  • 16

    Jul

  • 23

    Jul

  • 09

    Sep

  • 16

    Sep

KMB Kimberly-Clark
$136.44

-2.09 (-1.51%)

04/23/19
MACQ
04/23/19
UPGRADE
MACQ
Outperform
Kimberly-Clark upgraded to Outperform from Neutral at Macquarie
04/23/19
ARGS
04/23/19
UPGRADE
ARGS
Buy
Kimberly-Clark upgraded to Buy from Hold at Argus
04/23/19
04/23/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst James Faucette citing his view that the market has "not yet fully appreciated" the impact of the company's settlement with Apple (AAPL), which he thinks not only increases earnings substantially while also expanding the freedom with which Qualcomm can pursue new opportunities. 2. Kimberly-Clark (KMB) upgraded to Buy from Hold at Argus and to Outperform from Neutral at Macquarie. 3. Sanderson Farms (SAFM) upgraded to Neutral from Sell at Goldman Sachs with analyst Adam Samuelson saying African swine fever is upending the protein markets, Samuelson tells investors in a research note. 4. Visteon (VC) upgraded to Outperform from Neutral at Baird while Veoneer (VNE) was upgraded to Neutral from Underperform. 5. Sony (SNE) upgraded to Outperform from Neutral at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/18/19
MSCO
06/18/19
NO CHANGE
Target $145
MSCO
Equal Weight
Morgan Stanley sees near-term upside in Kimberly-Clark from better input costs
The substantial decline in pulp prices recently, along with elevated pulp inventory levels, has materially changed Kimberly-Clark's input cost inflation outlook, according to Morgan Stanley analyst Dara Mohsenian. Given that the better input costs should drive near-term EPS upside, he is making a positive short-term trading call in the stock, predicting that the company will cut its input cost inflation guidance by $75M to $225-$325M and raise its FY19 EPS guidance to $6.60-6.80 from $6.50-6.70. Though Mohsenian raised his price target on Kimberly-Clark shares to $145 from $132, he keeps an Equal Weight rating on the stock on a longer-term view, as he still expects market share struggles and sees lower growth potential.
JNJ Johnson & Johnson
$141.27

0.295 (0.21%)

05/22/19
WELS
05/22/19
NO CHANGE
WELS
Wells Fargo says start of opioid trial won't be positive for Teva shares
Wells Fargo analyst David Maris noted that the nation's first major opioid case, brought against Teva (TEVA) and Johnson & Johnson (JNJ) in Oklahoma, will begin on May 28 and that the entire trial will be webcast. He thinks that the trial start and the opening webcast statements "will not be positive for Teva shares," adding that he suspects the outcome of this suit will be extrapolated to the Multi-District Litigation coming this fall. Maris keeps a Market Perform rating on Teva shares.
05/28/19
GSCO
05/28/19
INITIATION
Target $163
GSCO
Buy
Johnson & Johnson initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Terence Flynn started Johnson & Johnson with a Buy rating and $163 price target. J&J's diversified portfolio is a potential strength as it results in the company having the lowest exposure to Medicare/Medicaid within the group, Flynn tells investors in a research note. As a result, he thinks the stock will be less impacted by potential drug pricing headlines/policy proposals ahead of the 2020 presidential election.
05/30/19
WELS
05/30/19
NO CHANGE
WELS
Outperform
Johnson & Johnson concerns over opioid case seem 'overblown,' says Wells Fargo
As the first state opioid trial begins in Oklahoma, Wells Fargo analyst Larry Biegelsen continues to believe that litigation will be manageable for Johnson & Johnson given its size and resources. The analyst notes that it appears the company's pain products - Duragesic patch and Nucynta/ER - accounted for less than 1% of the Oklahoma Medicaid opioid prescriptions from 1996-2017, while the company's slides also show data that fentanyl and tapentadol have lower abuse rates and diversion rates versus oxycodone and hydrocodone. Overall, Biegelsen believes concerns over the Oklahoma opioid case "may be overblown." The analyst has an Outperform rating on the shares.
05/30/19
COWN
05/30/19
NO CHANGE
Target $155
COWN
Outperform
Johnson & Johnson weakness may be overdone, says Cowen
Cowen analyst Joshua Jennings noted the State of Oklahoma is claiming Janssen Pharmaceuticals helped fuel the US opioid crisis which then caused volatility in Johnson & Johnson (JNJ) shares. While JNJ maintains its involvement was limited, the analyst says it is challenging to estimate the potential liability. His analysis however suggests, the stock's pullback is overdone. Jennings maintained his Outperform rating and $155 price target on Johnson & Johnson shares.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,992.41

-17.59 (-0.88%)

08:54
07/18/19
07/18
08:54
07/18/19
08:54
Periodicals
Amazon's Go outlets in Chicago falling short of expectations, Bloomberg reports »

Amazon's Go…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

WP

Worldpay

$132.28

1.07 (0.82%)

08:52
07/18/19
07/18
08:52
07/18/19
08:52
Initiation
Worldpay initiated  »

Worldpay assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONEXF

Onex

$0.00

(0.00%)

08:52
07/18/19
07/18
08:52
07/18/19
08:52
Hot Stocks
Onex to sell Jack's Family Restaurants, terms not disclosed »

Onex Corporation and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$39.03

-0.87 (-2.18%)

, FB

Facebook

$201.97

-1.9 (-0.93%)

08:51
07/18/19
07/18
08:51
07/18/19
08:51
Recommendations
eBay, Facebook analyst commentary  »

eBay price target raised…

EBAY

eBay

$39.03

-0.87 (-2.18%)

FB

Facebook

$201.97

-1.9 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

WEX

Wex

$218.50

0.11 (0.05%)

08:51
07/18/19
07/18
08:51
07/18/19
08:51
Initiation
Wex initiated  »

Wex assumed with a Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOK

MyoKardia

$49.90

-0.21 (-0.42%)

08:50
07/18/19
07/18
08:50
07/18/19
08:50
Hot Stocks
MyoKardia expects cash, cash equivalents to fund operations into 2H21 »

MyoKardia's cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

V

Visa

$179.16

-0.14 (-0.08%)

08:50
07/18/19
07/18
08:50
07/18/19
08:50
Initiation
Visa initiated  »

Visa assumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

TSS

TSYS

$133.04

0.06 (0.05%)

08:50
07/18/19
07/18
08:50
07/18/19
08:50
Initiation
TSYS initiated  »

TSYS assumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIR

Circor

$37.12

-1.22 (-3.18%)

08:50
07/18/19
07/18
08:50
07/18/19
08:50
Upgrade
Circor rating change  »

Circor upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

MYOK

MyoKardia

$49.90

-0.21 (-0.42%)

, SNY

Sanofi

$41.57

-0.25 (-0.60%)

08:49
07/18/19
07/18
08:49
07/18/19
08:49
Hot Stocks
MyoKardia re-acquires U.S. royalty rights to HCM programs from Sanofi »

MyoKardia (MYOK)…

MYOK

MyoKardia

$49.90

-0.21 (-0.42%)

SNY

Sanofi

$41.57

-0.25 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

  • 09

    Sep

  • 16

    Sep

  • 23

    Sep

  • 02

    Oct

SQ

Square

$80.81

0.23 (0.29%)

08:49
07/18/19
07/18
08:49
07/18/19
08:49
Initiation
Square initiated  »

Square assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

TMDI

Titan Medical

$2.19

-0.025 (-1.13%)

08:49
07/18/19
07/18
08:49
07/18/19
08:49
Hot Stocks
Titan Medical completes GLP procedures with single-port robotic surgery system »

Titan Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$118.80

-0.88 (-0.74%)

08:49
07/18/19
07/18
08:49
07/18/19
08:49
Initiation
PayPal initiated  »

PayPal assumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

MYOK

MyoKardia

$49.90

-0.21 (-0.42%)

08:48
07/18/19
07/18
08:48
07/18/19
08:48
Hot Stocks
MyoKardia expects to report topline data from EXPLORER-HCM trial in 2Q20 »

MyoKardia announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

MA

MasterCard

$275.34

-1.1 (-0.40%)

08:48
07/18/19
07/18
08:48
07/18/19
08:48
Initiation
MasterCard initiated  »

MasterCard assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

GDOT

Green Dot

$47.85

-0.525 (-1.09%)

08:47
07/18/19
07/18
08:47
07/18/19
08:47
Initiation
Green Dot initiated  »

Green Dot assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPN

Global Payments

$165.06

0.215 (0.13%)

08:47
07/18/19
07/18
08:47
07/18/19
08:47
Initiation
Global Payments initiated  »

Global Payments assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 13

    Nov

FLT

FleetCor

$289.72

-1.21 (-0.42%)

08:46
07/18/19
07/18
08:46
07/18/19
08:46
Initiation
FleetCor initiated  »

FleetCor assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$102.27

-3.07 (-2.91%)

08:46
07/18/19
07/18
08:46
07/18/19
08:46
Earnings
Genuine Parts updates FY19 revenue growth view to 4.5%-5.5%, consensus $19.55B »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

SPNE

SeaSpine

$12.73

(0.00%)

08:45
07/18/19
07/18
08:45
07/18/19
08:45
Hot Stocks
SeaSpine announces release of OsteoStrand, OsteoStrand Plus DBM Fibers »

SeaSpine Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.56

0.26 (4.13%)

, SAP

SAP

$134.22

-0.9 (-0.67%)

08:45
07/18/19
07/18
08:45
07/18/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

APHA

Aphria

$6.56

0.26 (4.13%)

SAP

SAP

$134.22

-0.9 (-0.67%)

OSTK

Overstock.com

$18.90

1.13 (6.36%)

SIL

APEX Silver Mines

$28.29

1.23 (4.55%)

FCEL

FuelCell

$0.31

-0.014 (-4.38%)

TZA

Small Cap Bear 3x

$46.85

1.05 (2.29%)

TLT

iShares 20+ Year Treasury Bond Fund

$131.99

1.42 (1.09%)

SQQQ

ProShares UltraPro Short QQQ

$32.21

0.42 (1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 01

    Aug

  • 01

    Aug

08:45
07/18/19
07/18
08:45
07/18/19
08:45
General news
U.S. initial jobless claims rose 8k to 216k in the week ended July 13 »

U.S. initial jobless…

MS

Morgan Stanley

$43.78

-0.63 (-1.42%)

08:44
07/18/19
07/18
08:44
07/18/19
08:44
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley »

Morgan Stanley CFO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 11

    Sep

MS

Morgan Stanley

$43.78

-0.63 (-1.42%)

08:44
07/18/19
07/18
08:44
07/18/19
08:44
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley »

Morgan Stanley CFO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 11

    Sep

MS

Morgan Stanley

$43.78

-0.63 (-1.42%)

08:43
07/18/19
07/18
08:43
07/18/19
08:43
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley »

Morgan Stanley CFO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 11

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.